Submission Details
| 510(k) Number | K162423 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2016 |
| Decision Date | January 03, 2017 |
| Days to Decision | 126 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K162423 is an FDA 510(k) clearance for the Haemonetics Cell Saver Elite/Elite+ Autotransfusion System, a Apparatus, Autotransfusion (Class II — Special Controls, product code CAC), submitted by Haemonetics Corporation (Braintree, US). The FDA issued a Cleared decision on January 3, 2017, 126 days after receiving the submission on August 30, 2016. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5830.
| 510(k) Number | K162423 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2016 |
| Decision Date | January 03, 2017 |
| Days to Decision | 126 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CAC — Apparatus, Autotransfusion |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5830 |